Devonian Health Group Inc
XTSX:GSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Devonian Health Group Inc
Intangible Assets
Devonian Health Group Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Devonian Health Group Inc
XTSX:GSD
|
Intangible Assets
CA$4.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Intangible Assets
$4.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-15%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Intangible Assets
CA$76.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
3%
|
|
|
Cronos Group Inc
TSX:CRON
|
Intangible Assets
$8.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
22%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Intangible Assets
CA$379.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
19%
|
CAGR 10-Years
61%
|
|
Devonian Health Group Inc
Glance View
Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. The company is headquartered in Pointe-Claire, Quebec. The company went IPO on 2014-09-09. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The anti-inflammatory, anti-oxidative and immunomodulatory properties of Thykamine have been demonstrated by a considerable number of in vitro and in vivo studies, as well as in a Phase IIa clinical study in patients with Mild-to-Moderate distal Ulcerative Colitis and in a Phase II clinical trial in adult patients with Mild-to-Moderate Atopic Dermatitis. The firm is also involved in the development of cosmeceutical products.
See Also
What is Devonian Health Group Inc's Intangible Assets?
Intangible Assets
4.9m
CAD
Based on the financial report for Oct 31, 2025, Devonian Health Group Inc's Intangible Assets amounts to 4.9m CAD.
What is Devonian Health Group Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-6%
Over the last year, the Intangible Assets growth was -4%. The average annual Intangible Assets growth rates for Devonian Health Group Inc have been -4% over the past three years , -6% over the past five years .
